Australia Patient Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Australia Patient Monitoring Devices & Companies and it is Segmented by Type of Device (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring, Multi-parameter Monitors, Respiratory Monitoring Devices, Remote Patient Monitoring Devices and Other Types of Devices) , Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, and Other Applications), End-User (Home Healthcare, Hospitals and Clinics and Other End Users). The market provides the value (in USD million) for the above segments.

Australia Patient Monitoring Market Size

View Global Report
CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 1.23 Billion
Market Size (2029) USD 1.74 Billion
CAGR (2024 - 2029) 7.21 %
Market Concentration Medium

Major Players

Australia Patient Monitoring Market

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Australia Patient Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Australia Patient Monitoring Market Analysis

The Australia Patient Monitoring Market size is estimated at USD 1.23 billion in 2024, and is expected to reach USD 1.74 billion by 2029, growing at a CAGR of 7.21% during the forecast period (2024-2029).

COVID-19 is expected to impact positively on the growth of the market in Australia. According to the article titled ' Virtual Health Care for Community Management of Patients with COVID-19 in Australia: Observational Cohort Study' published in March 2021, 81.5% of patients were monitored remotely. Thus, the sudden outbreak of COVID-19 is expected to drive the growth of the market during the forecast period.

Australia's market for patient monitoring devices is witnessing rapid growth in recent times. This is due to the advances on the technological forefront, larger patient pool, and lenient regulatory framework. Other key factors boosting the market growth are an increase in the chronic disease population and a rise in the aging population. According to data published by the Australian Government's Department of Health in September 2021, cardiovascular diseases account for 27% of all deaths in Australia. Approximately 1.2 million Australians suffer from one or more cardiac or vascular diseases. According to the estimates of the Global Cancer Observatory, in 2020, there were an estimated 200,021 new cancer cases diagnosed and 48,236 cancer deaths in Australia. According to the Australian Institutes of Health and welfare 2020 report estimated that in 2020 there were between 400,000 and 459,000 Australians with dementia, with Alzheimer's disease accounting for up to 70% of diagnosed cases. Alzheimer's dementia is the most common type of dementia that occurs in Australia. Therefore the growing burden of such diseases is expected to increase the demand for monitoring systems in the market during the forecast period.

However, the resistance from the healthcare industry professionals towards the adoption of the patient monitoring systems and lack of proper reimbursement policies is restraining the market growth

Australia Patient Monitoring Market Trends

This section covers the major market trends shaping the Australia Patient Monitoring market according to our research experts:

Weight Management & Fitness Monitoring is Expected to Show a Significant Growth Rate During the Forecast Period

The adoption of a sedentary lifestyle in the Australian population, such as physical inactivity, poor diet, high consumption of sugar, etc. has led to many chronic conditions such as diabetes, obesity, cardiovascular diseases, and others. As per the article titled ' 15 Obesity statistics Australia should know about (2022) ' published in January 2022 mentioned that one in 3 Australian was obese which equates to about 8.3 million Aussies. The report also mentioned that 14.56 million Australians were overweight or obese which was 57.30% of the country's entire population. Hence. such an obese population is expected to increase the demand for patient monitoring during the forecast period. Hence, it has become essential to manage these patients' overall health, and therefore, these factors are expected to increase the demand for weight management & fitness monitoring.

Also , the increasing government initiatives for the weight management is also expected to drive the growth of the segment during the forecats period. According to the article titled 'Evaluation of a Lifestyle and Weight Management Programs Within Rural General Practice'published in March 2022 in response to increasing rates of overweight and obesity in rural Australia, one regional primary health networl commissioned the development of a multi-faced weight and lifestyle management program, addressing nutrition, physical activity and psychological approaches to behavioural change.

Thus the above mentioned factors are expected to drive the growth of the studied segment, thereby contributing to the growth of the market during the forecast period.

obesity

Australia Patient Monitoring Industry Overview

The Australian patient monitoring market consists of several major players. The competitive landscape includes an analysis of a few international as well as local companies which hold the maximum market shares and are well known include Baxter International Inc., Nihon Kohden Corporation, MIndray Medical International Co., Ltd, Boston Scientific Corporation, General Electric Company, Johnson and Johnson, Medtronic, Masimo Corporation and Others.

Australia Patient Monitoring Market Leaders

  1. Koninklijke Philips N.V

  2. Mindray Medical International Co. Ltd.

  3. Nihon Kohden Corporation

  4. Baxter International Inc.

  5. Siemens Healthcare GmbH

*Disclaimer: Major Players sorted in no particular order

Australia Patient Monitoring Market.png
Need More Details on Market Players and Competitors?
Download PDF

Australia Patient Monitoring Market News

  • In January 2022, MDLIVE launched patient health monitoring to drive health improvements for people living with chronic conditions. This digital-first program aims to improve health outcomes for people living with chronic health conditions like diabetes, heart disease, or high blood pressure.
  • In January 2022, Omron Healthcare launched heart-focused remote patient monitoring. This launch would expand digital health services to consumers and monitor risks of heart disease and other ailments.

Australia Patient Monitoring Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidences of Chronic Diseases due to Lifestyle Changes

      2. 4.2.2 Growing Preference for Home and Remote Monitoring

    3. 4.3 Market Restraints

      1. 4.3.1 Resistance from the Healthcare Industry Professionals Toward the Adoption of Patient Monitoring Systems

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Type of Device

      1. 5.1.1 Hemodynamic Monitoring Devices

      2. 5.1.2 Neuromonitoring Devices

      3. 5.1.3 Cardiac Monitoring Devices

      4. 5.1.4 Multi-parameter Monitors

      5. 5.1.5 Respiratory Monitoring Devices

      6. 5.1.6 Remote Patient Monitoring Devices

      7. 5.1.7 Other Types of Devices

    2. 5.2 By Application

      1. 5.2.1 Cardiology

      2. 5.2.2 Neurology

      3. 5.2.3 Respiratory

      4. 5.2.4 Fetal and Neonatal

      5. 5.2.5 Weight Management and Fitness Monitoring

      6. 5.2.6 Other Applications

    3. 5.3 By End Users

      1. 5.3.1 Home Healthcare

      2. 5.3.2 Hospitals and Clinics

      3. 5.3.3 Other End Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Baxter International Inc.

      2. 6.1.2 Nihon Kohden Corporation

      3. 6.1.3 Mindray Medical International Co. Ltd.

      4. 6.1.4 Boston Scientific Corporation

      5. 6.1.5 General Electric Company (GE Healthcare)

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Medtronic Care Management Services LLC

      8. 6.1.8 Koninklijke Philips NV

      9. 6.1.9 Masimo Corporation

      10. 6.1.10 Siemens Healthcare GmbH

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Australia Patient Monitoring Industry Segmentation

As per the scope of this report, patient monitoring devices are monitoring devices that continuously monitor the patient's vital parameters, like blood pressure and heart rates, by using a medical monitor and collecting medical (and other) data from individuals. The Australia Patient Monitoring Market is segmented by Type of Devices (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring, Multi-parameter Monitors, Respiratory Monitoring Devices, Remote Patient Monitoring Devices and Other Types of Devices), Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, and Other Applications), End-User ( Home Healthcare, Hospitals and Clinics and Other End Users). The report offers the value (in USD million) for the above segments.

By Type of Device
Hemodynamic Monitoring Devices
Neuromonitoring Devices
Cardiac Monitoring Devices
Multi-parameter Monitors
Respiratory Monitoring Devices
Remote Patient Monitoring Devices
Other Types of Devices
By Application
Cardiology
Neurology
Respiratory
Fetal and Neonatal
Weight Management and Fitness Monitoring
Other Applications
By End Users
Home Healthcare
Hospitals and Clinics
Other End Users
Need A Different Region Or Segment?
Customize Now

Australia Patient Monitoring Market Research FAQs

The Australia Patient Monitoring Market size is expected to reach USD 1.23 billion in 2024 and grow at a CAGR of 7.21% to reach USD 1.74 billion by 2029.

In 2024, the Australia Patient Monitoring Market size is expected to reach USD 1.23 billion.

Koninklijke Philips N.V, Mindray Medical International Co. Ltd., Nihon Kohden Corporation, Baxter International Inc. and Siemens Healthcare GmbH are the major companies operating in the Australia Patient Monitoring Market.

In 2023, the Australia Patient Monitoring Market size was estimated at USD 1.15 billion. The report covers the Australia Patient Monitoring Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Australia Patient Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Australia Patient Monitoring Industry Report

Statistics for the 2024 Australia Patient Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Australia Patient Monitoring analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Australia Patient Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)